Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active reference

Rezultati

Naziv:	Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active reference
Autori:	Ward, Caroline; Pejović-Milovančević, Milica ; Kohegyi, Eva; Hefting, Nanco; Aurang, Catherine; Chen, Dalei; Larsen, Klaus Groes; Hobart, Mary; Correll, Christoph U.
Godina:	2025
Publikacija:	The lancet. Psychiatry
ISSN:	2215-0366 Pretraži identifikator
Izdavač:	Kidlington, Oxford : Elsevier
Tip rezultata:	Naučni članak
Kolacija:	vol. 12 br. 5 str. 345-354
DOI:	10.1016/S2215-0366(25)00043-4
WoS-ID:	001472033400001
Scopus-ID:	2-s2.0-105002567652
PMID:	40209740
URI:	https://enauka.gov.rs/handle/123456789/980808
URL:	https://www.sciencedirect.com/science/article/pii/S2215036625000434?via%3Dihub
Projekat:	Otsuka Pharmaceutical Development & Commercialization H Lundbeck
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

8
SCOPUS^TM

4
PubMed Central^TM

6
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.